EXTL2
Basic information
Region (hg38): 1:100872372-100895179
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXTL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 3 | 0 |
Variants in EXTL2
This is a list of pathogenic ClinVar variants found in the EXTL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-100874040-T-G | not specified | Uncertain significance (Sep 22, 2023) | ||
1-100874101-A-T | not specified | Uncertain significance (May 11, 2022) | ||
1-100874130-T-C | not specified | Uncertain significance (Aug 06, 2024) | ||
1-100874149-T-C | not specified | Uncertain significance (Sep 24, 2024) | ||
1-100874172-G-T | not specified | Uncertain significance (Nov 10, 2024) | ||
1-100874231-G-A | not specified | Uncertain significance (Feb 07, 2025) | ||
1-100874247-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
1-100874275-G-T | not specified | Uncertain significance (Jan 21, 2025) | ||
1-100874313-A-G | not specified | Uncertain significance (Aug 01, 2024) | ||
1-100874370-T-C | not specified | Likely benign (Nov 21, 2024) | ||
1-100876805-A-C | not specified | Uncertain significance (Dec 12, 2023) | ||
1-100876825-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
1-100877553-A-G | not specified | Uncertain significance (May 08, 2023) | ||
1-100877589-G-T | not specified | Uncertain significance (Apr 26, 2023) | ||
1-100877592-G-A | not specified | Uncertain significance (Oct 09, 2024) | ||
1-100877641-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
1-100877644-C-T | not specified | Likely benign (Nov 09, 2023) | ||
1-100877722-T-A | not specified | Likely benign (Jun 22, 2024) | ||
1-100877754-C-T | not specified | Uncertain significance (Jan 17, 2025) | ||
1-100877796-G-A | not specified | Uncertain significance (Dec 12, 2022) | ||
1-100877820-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
1-100877827-C-T | not specified | Uncertain significance (Jun 28, 2024) | ||
1-100877856-A-G | not specified | Uncertain significance (Feb 01, 2025) | ||
1-100877863-T-C | not specified | Uncertain significance (Feb 14, 2025) | ||
1-100877877-C-T | not specified | Uncertain significance (Dec 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EXTL2 | protein_coding | protein_coding | ENST00000370114 | 4 | 23612 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000176 | 0.898 | 125648 | 0 | 36 | 125684 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.831 | 146 | 177 | 0.824 | 0.00000835 | 2188 |
Missense in Polyphen | 51 | 66.509 | 0.76682 | 871 | ||
Synonymous | 0.315 | 58 | 61.1 | 0.949 | 0.00000289 | 621 |
Loss of Function | 1.49 | 8 | 14.0 | 0.571 | 8.67e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000127 | 0.000127 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000151 | 0.000150 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosyltransferase required for the biosynthesis of heparan-sulfate and responsible for the alternating addition of beta-1-4-linked glucuronic acid (GlcA) and alpha-1-4-linked N- acetylglucosamine (GlcNAc) units to nascent heparan sulfate chains. {ECO:0000269|PubMed:10318803}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);XBP1(S) activates chaperone genes;Proteoglycan biosynthesis;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.387
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.69
Haploinsufficiency Scores
- pHI
- 0.553
- hipred
- N
- hipred_score
- 0.306
- ghis
- 0.562
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.107
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Extl2
- Phenotype
- cellular phenotype;
Gene ontology
- Biological process
- N-acetylglucosamine metabolic process;protein glycosylation;heparan sulfate proteoglycan biosynthetic process;UDP-N-acetylgalactosamine metabolic process;IRE1-mediated unfolded protein response
- Cellular component
- extracellular region;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;glycosaminoglycan binding;manganese ion binding;alpha-1,4-N-acetylgalactosaminyltransferase activity;glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity